127 related articles for article (PubMed ID: 1436300)
1. Severe tubulopathy and kidney graft rupture after coadministration of mannitol and ciclosporin.
Biesenbach G; Zazgornik J; Kaiser W; Grafinger P; Stuby U; Gross C; Hartl P; Brücke P
Nephron; 1992; 62(1):93-6. PubMed ID: 1436300
[TBL] [Abstract][Full Text] [Related]
2. Modifying cyclosporine associated renal allograft dysfunction.
Mohapatra N; Vanikar AV; Patel RD; Trivedi HL
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):770-4. PubMed ID: 19736471
[TBL] [Abstract][Full Text] [Related]
3. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical markers of renal tubular injury and cyclosporin nephrotoxicity in kidney allograft biopsies.
García Del Moral R; Navarro N; Montes A; Aguilar D; Aneiros J
Nephron; 1992; 62(1):121-2. PubMed ID: 1436283
[No Abstract] [Full Text] [Related]
5. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.
Clin Nephrol; 1985 Sep; 24(3):107-19. PubMed ID: 3899437
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous improvement of renal function following renal allograft rupture associated with acute rejection.
Chan TM; Kwok TF; Yap FH; Cheng IK
Clin Transplant; 1995 Apr; 9(2):71-3. PubMed ID: 7599404
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous renal allograft rupture without rejection: a case report.
Anderson B; Sampson C; Callender CO
J Urol; 1976 Jun; 115(6):745-6. PubMed ID: 781313
[TBL] [Abstract][Full Text] [Related]
8. Isometric tubular vacuolization in renal transplant recipient: the first case report in Thailand.
Ruangkanchanasetr P; Praechinavong W; Paueksakon P; Satirapoj B; Supasyndh O; Supaporn T
J Med Assoc Thai; 2012 May; 95 Suppl 5():S168-71. PubMed ID: 22934464
[TBL] [Abstract][Full Text] [Related]
9. Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats.
Kim JY; Suh KS
J Korean Med Sci; 1995 Oct; 10(5):352-9. PubMed ID: 8750061
[TBL] [Abstract][Full Text] [Related]
10. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.
Budde K; Becker T; Arns W; Sommerer C; Reinke P; Eisenberger U; Kramer S; Fischer W; Gschaidmeier H; Pietruck F;
Lancet; 2011 Mar; 377(9768):837-47. PubMed ID: 21334736
[TBL] [Abstract][Full Text] [Related]
11. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
12. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
14. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.
Dantal J; Hourmant M; Cantarovich D; Giral M; Blancho G; Dreno B; Soulillou JP
Lancet; 1998 Feb; 351(9103):623-8. PubMed ID: 9500317
[TBL] [Abstract][Full Text] [Related]
15. The Cairo kidney center protocol for rapamycin-based sequential immunosuppression in kidney transplant recipients: 2-year outcomes.
Barsoum RS; Morsey AA; Iskander IR; Morgan MM; Fayad TM; Atalla NT; Wafik H; Grace RA; Adel N; Khalil SS
Exp Clin Transplant; 2007 Dec; 5(2):649-57. PubMed ID: 18194116
[TBL] [Abstract][Full Text] [Related]
16. Renal allograft rupture and its management.
Yadav RV; Sinha R; Datta BN
Int Surg; 1985; 70(4):361-3. PubMed ID: 3914474
[TBL] [Abstract][Full Text] [Related]
17. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone.
Sibley RK; Rynasiewicz J; Ferguson RM; Fryd D; Sutherland DE; Simmons RL; Najarian JS
Surgery; 1983 Aug; 94(2):225-34. PubMed ID: 6348988
[TBL] [Abstract][Full Text] [Related]
18. Conversion from cyclosporine to sirolimus in chronic renal allograft dysfunction: a 4-year prospective study.
Han F; Wu J; Huang H; Zhang X; He Q; Wang Y; Wang S; Wang H; Chen J
Exp Clin Transplant; 2011 Feb; 9(1):42-9. PubMed ID: 21605022
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
Jankauskiene A; Druskis V; Laurinavicius A
Clin Nephrol; 2001 Dec; 56(6):S27-9. PubMed ID: 11770808
[TBL] [Abstract][Full Text] [Related]
20. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
Goldfarb DA
J Urol; 2005 Jun; 173(6):2106-7. PubMed ID: 15879857
[No Abstract] [Full Text] [Related]
[Next] [New Search]
